Kiniksa Pharmaceuticals International (KNSA) Equity Ratio (2021 - 2025)
Kiniksa Pharmaceuticals International (KNSA) has disclosed Equity Ratio for 5 consecutive years, with 0.74 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Equity Ratio fell 1.58% year-over-year to 0.74, compared with a TTM value of 0.74 through Dec 2025, down 1.58%, and an annual FY2025 reading of 0.74, down 1.58% over the prior year.
- Equity Ratio was 0.74 for Q4 2025 at Kiniksa Pharmaceuticals International, down from 0.75 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.88 in Q1 2023 and bottomed at 0.72 in Q1 2022.
- Average Equity Ratio over 5 years is 0.8, with a median of 0.82 recorded in 2024.
- The sharpest move saw Equity Ratio dropped 17.26% in 2022, then increased 22.38% in 2023.
- Year by year, Equity Ratio stood at 0.79 in 2021, then grew by 8.43% to 0.86 in 2022, then fell by 3.25% to 0.83 in 2023, then decreased by 9.42% to 0.76 in 2024, then fell by 1.58% to 0.74 in 2025.
- Business Quant data shows Equity Ratio for KNSA at 0.74 in Q4 2025, 0.75 in Q3 2025, and 0.75 in Q2 2025.